Clinical Trials Browser

Rectal Neoplasms

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Rectal Cancer Patients

Stomach Neoplasms

Rectal Neoplasms

Locally Advanced Colorectal Cancer

Locally Advanced Rectal Cancer

Nasopharyngeal Carcinoma

Breast Neoplasms

Colorectal Neoplasms

Rectal Neoplasms Malignant

Locally Advanced Rectal Cancer (LARC)

Nasopharyngeal Carcinoma

Colorectal Neoplasms

Cholangiocarcinoma

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Colorectal Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Liver Neoplasms

Esophageal Neoplasms, Colorectal Neoplasms

CLDN18.2-positive Advanced Biliary Tract Cancer

Disease, Colorectal Neoplasms

Breast Neoplasms

HER2-positive Gastric Cancer

Nasopharyngeal Carcinoma

Adenocarcinoma

Rectal Neoplasms

Nasopharyngeal Neoplasms, Recurrence

Stomach Neoplasms

Colonic Neoplasms

Colorectal Cancer Liver Metastasis

Breast Neoplasms, Triple Negative Breast Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Liver Metastases of Colorectal Cancer

Breast Neoplasms

Metastatic Breast Cancer in the Brain

Advanced Solid Tumor

Rectal Neoplasms

Brain Neoplasms

Nasopharyngeal Carcinoma

Stomach Neoplasms

Rectal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Stomach Neoplasms

Esophageal Squamous Cell Carcinoma

Immunotherapy

MSI-H Colorectal Cancer

Clinical Trials

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer

IMMUNOSTAR

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Adjuvant Chemotherapy for BTC Based on 3D-PTA

CAPTURE

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

SMARTi-RC01

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

JSKN003 Combined Treatment of HER2-positive Gastric Cancer

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM

Calorite

FDZL-GC003

TRACER

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer

A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer